Blood Cancer Clinical Trials in Chicago

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms
Recruiting
  • IDH Mutation
  • +4 more
  • Chicago, Illinois
    University of Chicago Medical Center
2021-11-12
Nov 12, 2021
M
Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL - 2021
Terminated
  • Non-Hodgkin's B-cell Lymphoma
  • +5 more
  • MT-3724 Phase 1
  • MT-3724 Phase 2
  • Tucson, Arizona
  • +40 more
2021-08-30
Aug 30, 2021